Stay updated on XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial
Sign up to get notified when there's something new on the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page.

Latest updates to the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedUpdated the page’s displayed revision/version number from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check23 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page now displays Revision: v3.5.0, and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a version update and does not change the study content visible on the page.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No user-facing content appears to be altered, including study details or results.SummaryDifference0.1%

- Check95 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page; no substantive content changes.SummaryDifference0.1%

Stay in the know with updates to XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XM02 vs. Filgrastim + Plerixafor in Stem Cell Mobilization Clinical Trial page.